Genitourinary cancers: molecular determinants for personalized therapies

Roberta Mazzucchelli, Silvia Gasparrini, Andrea B. Galosi, Francesco Massari, Maria Rosaria Raspollini, Marina Scarpelli, Antonio Lopez-Beltran, Liang Cheng, Rodolfo Montironi

Research output: Contribution to journalEditorial

1 Scopus citations

Abstract

Recent insights and emerging strategies for individualized therapeutic approaches in patients with genitourinary (GU) cancers are based on patient's genomic and cancer's molecular profiles. This depends on the significant advances made in molecular biology technologies, such as next-generation sequencing and whole-exome sequencing. The rise of such novel techniques has grayly increased our knowledge on cancer cell biology and development, thus allowing to identify complex abnormalities at the genomic level. These findings have paved the way toward what is called precision medicine, thus providing healthcare from an individual perspective in patients with GU tumors.

Original languageEnglish (US)
Pages (from-to)107-109
Number of pages3
JournalUrologia
Volume83
Issue number3
DOIs
StatePublished - Sep 26 2016

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Genitourinary cancers: molecular determinants for personalized therapies'. Together they form a unique fingerprint.

  • Cite this

    Mazzucchelli, R., Gasparrini, S., Galosi, A. B., Massari, F., Raspollini, M. R., Scarpelli, M., Lopez-Beltran, A., Cheng, L., & Montironi, R. (2016). Genitourinary cancers: molecular determinants for personalized therapies. Urologia, 83(3), 107-109. https://doi.org/10.5301/uro.5000187